Please select the outcome measures that correspond to the clinical trial below.
Title: Efficacy of Dialectical Behavior Therapy in Patient With Self Harming Behavior and Traits Within the Spectrum of Borderline Personality Disorder.
Brief Summary: Purpose: The purpose of this study is to investigate the efficacy of Dialectical Behavior Therapy (DBT) versus CAMS (Collaborative Assessment and Management of Suicidality) -informed supportive psychotherapy on the risk of self-harm acts and suicide attempts in patients with self behavior and personality traits within the spectrum of borderline personality disorder.

Hypothesis: The hypothesis is 16 weeks of treatment with Dialectical Behavior Therapy (DBT) after a defined manual has a higher efficacy than CAMS-informed supportive psychotherapy on self-harm acts, suicide attempts, suicidal ideation, depressive symptoms, impulsiveness and consumption of hospital services in patients with symptoms within the spectrum of borderline personality disorder (BDP).

Method: The investigators will include 160 patients in the randomized trial to investigate whether 16 weeks of DBT-treatment as a higher efficacy than CAMS-informed supportive psychotherapy on the risk of self-harm acts and suicide attempts in patients with self-harm behavior and personality traits within the spectrum of borderline personality disorder. The trial will meet strict criteria for high quality randomized trials, and will hopefully help to establish evidence for the treatment of this patient group at higher risk of later suicide. There will be performed follow up interviews after 16 weeks, 28 weeks and 52 weeks.


Options:
A: adolescent alcohol use and binge drinking (any, number of days, number of related problems) (change from baseline to 6 months (prior 3 months)); adolescent suicidal ideation and behavior (severity of suicidal ideation and presence of any suicidal ideation or suicidal behavior) (change from baseline to 6 months (prior month to 6 months)); adolescent HIV risk behavior (any sexual behavior, number of sexual partners, number of unprotected sexual acts) (change from baseline to 6 months (prior 3 months)); adolescent marijuana use (any use, number of days, related problems) (change from baseline to 6 months (prior 3 months)); adolescent alcohol use and binge drinking (any, number of days, number of related problems) (change from baseline to 12 months (prior 3 months)); adolescent suicidal ideation and behavior (severity of suicidal ideation and presence of any suicidal ideation or suicidal behavior) (change from baseline to 12 months (prior month to 6 months)); adolescent HIV risk behavior (any sexual behavior, number of sexual partners, number of unprotected sexual acts) (change from baseline to 12 months (prior 3 months)); adolescent marijuana use (any use, number of days, related problems) (change from baseline to 12 months (prior 3 months))
B: Change in BHS Scores (Baseline, 6 weeks, and 12 weeks)
C: Number of repeated self-harming acts including suicide attempts (change in number of self-harming acts). (Week 0 (baseline), 17, 28, 52.)
D: Acceptability of the intervention assessed by the number of therapy sessions completed by participants in the intervention arm. (2 years); Incidence of Treatment-Emergent Adverse Events as assessed by the adverse experiences in psychotherapy self-reported measure (2 years); Feasibility of the intervention assessed by the number of assessments completed by participants in the intervention arm (2 years)

Answer: C